International audienceAmyloid beta (Aβ) peptides are known to accumulate in the brain of patients with Alzheimer's disease (AD). However, the link between brain amyloidosis and clinical symptoms has not been elucidated and could be mediated by secondary neuropathological alterations such as fiber tracts anomalies. In the present study, we have investigated the impact of Aβ overproduction in APPxPS1 transgenic mice on the integrity of forebrain axonal bundles (corpus callosum and anterior commissure). We found evidence of fiber tract volume reductions in APPxPS1 mice that were associated with an accelerated age-related loss of axonal neurofilaments and a myelin breakdown. The severity of these defects was neither correlated with the density ...
According to the "amyloid hypothesis of Alzheimer's disease," beta-amyloid is the primary driving fo...
Cerebellar amyloid-β (Aβ) deposition in the form of neuritic plaques and Purkinje cell loss are comm...
We describe the thorough characterisation of a new transgenic mouse line overexpressing the 695-amin...
International audienceAmyloid-β peptide species accumulating in the brain of patients with Alzheimer...
Abstract- Alzheimer’s disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is ...
BACKGROUND: The deposition of the amyloid β-peptide (Aβ) in the brain is one of the hallmarks of Alz...
Alzheimer's disease is a fatal neurodegenerative disorder affecting the aging population. Neuroimagi...
Alzheimer’s disease is a neurodegenerative disease that has many pathological features including; pl...
The deposition of the amyloid ß-peptide (Aß) in the brain is one of thee hallmarks of Alzheimer’ s d...
Deposition of amyloid beta-peptide (A beta) in cerebral vessel walls (cerebral amyloid angiopathy, C...
Even though the idea that amyloid beta peptide accumulation is the primary event in the pathogenesis...
Alzheimer's disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is not fully ...
The pathological accumulation of parenchymal and vascular amyloid-beta (Aβ) are the main hallmarks o...
Of all forms of dementia, Alzheimer's disease is the most prevalent. It is histopathologically chara...
The EC (entorhinal cortex) is fundamental for cognitive and mnesic functions. Thus damage to this ar...
According to the "amyloid hypothesis of Alzheimer's disease," beta-amyloid is the primary driving fo...
Cerebellar amyloid-β (Aβ) deposition in the form of neuritic plaques and Purkinje cell loss are comm...
We describe the thorough characterisation of a new transgenic mouse line overexpressing the 695-amin...
International audienceAmyloid-β peptide species accumulating in the brain of patients with Alzheimer...
Abstract- Alzheimer’s disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is ...
BACKGROUND: The deposition of the amyloid β-peptide (Aβ) in the brain is one of the hallmarks of Alz...
Alzheimer's disease is a fatal neurodegenerative disorder affecting the aging population. Neuroimagi...
Alzheimer’s disease is a neurodegenerative disease that has many pathological features including; pl...
The deposition of the amyloid ß-peptide (Aß) in the brain is one of thee hallmarks of Alzheimer’ s d...
Deposition of amyloid beta-peptide (A beta) in cerebral vessel walls (cerebral amyloid angiopathy, C...
Even though the idea that amyloid beta peptide accumulation is the primary event in the pathogenesis...
Alzheimer's disease (AD) is a uniquely human disorder. Although the pathogenesis of AD is not fully ...
The pathological accumulation of parenchymal and vascular amyloid-beta (Aβ) are the main hallmarks o...
Of all forms of dementia, Alzheimer's disease is the most prevalent. It is histopathologically chara...
The EC (entorhinal cortex) is fundamental for cognitive and mnesic functions. Thus damage to this ar...
According to the "amyloid hypothesis of Alzheimer's disease," beta-amyloid is the primary driving fo...
Cerebellar amyloid-β (Aβ) deposition in the form of neuritic plaques and Purkinje cell loss are comm...
We describe the thorough characterisation of a new transgenic mouse line overexpressing the 695-amin...